Abstract Stanniocalcin 2 (STC2) is a glycoprotein which is expressed in a broad spectrum of
tumour cells and tumour tissues derived from human breast, colorectum, stomach …

Lung metastasis is the leading cause of breast cancer-related death. The tumor
microenvironment contributes to the metastatic colonization of tumor cells in the lungs …

The glycoprotein stanniocalcin‐1 functions as a regulatory endocrine hormone that
maintains the balance of calcium and phosphorus in bony fish and as a paracrine/autocrine …

Abstract Background Stanniocalcin 1 (STC1) plays an integral role in ovarian cancer (OC).
However, the functional role of STC1 in metastasis, lipid metabolism and cisplatin (DDP) …

Breast cancer is a highly heterogeneous disease consisting of five disease subtypes with
distinct histological characteristics, clinical behaviors and prognostic features. Stanniocalcin …

Background Stanniocalcin-1 (STC1) is a well-studied oncogene that promotes different
types of cancer progression. However, the expression status of STC1, the values of STC1 on …

Organotypic three-dimensional (3D) cell cultures more accurately mimic the characteristics
of solid tumors in vivo in comparison with traditional two-dimensional (2D) monolayer cell …

Cisplatin (CDDP) is a widely used first-line chemotherapeutic drug in various cancers.
However, CDDP resistance is frequently observed in cancer patients. Therefore, it is …

Tumor immune escape has become a research hotspot in the field of cancer
immunotherapy. Tumor-associated macrophages (TAMs) are the key component of tumor …

Abstract Stanniocalcin-2 (STC2) is a glycoprotein that has been found to play key roles in
the regulation of cancer, diabetes mellitus, and osteogenesis. Herein we sought to extend …